In a study including a total of 57 patients with BD-I and BD-II, lower levels of glucagon-like peptide-1 (GLP-1) and ghrelin and higher levels of glucose-dependent insulinotropic polypeptide were found compared with controls and it was reported that these changes may play a role in the pathogenesis of BD [4]. This evidence concerns the gene GCG and Behcet disease.